Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
or insufficient. This is attributable, in large part, to differences in the types of interventions and, subsequently, in the mix of results. Looking closely within categories of design features, however, the following specific design features seemed to improve comprehension for low-health-literacy populations in one or a few studies: (1) presenting essential information by itself (i.e., information on hospital death rates without other distracting information, such as information on consumer satisfaction); (2) presenting essential information first (i.e., information on hospital death rates before information about consumer satisfaction); (3) presenting health plan quality information such that the higher number (rather than the. | European Technology Platform For further information on nanomedicine please contact Research DG Renzo Tomellini Uta Faure Oliver Panzer E-mail rtd-nanotech@ec.europa.eu http cordis.europa.eu nanotechnology nanomedicine.htm Europe Direct is a service to help you find answers to your questions about the European Union Freephone number 00 800 6 7 8 9 10 11 Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed. The Commission accepts no responsibility or liability whatsoever with regard to the information presented in this document. This brochure has been produced thanks to the efforts of the stakeholders group of the European Technology Platform on NanoMedicine. A great deal of additional information on the European Union is available on the internet. It can be accessed through the Europa server http ec.europa.eu . Reproduction is authorised provided the source is acknowledged. Photo cover G. von Bally Laboratory of Biophysics Medical Centre University of Munster Other pictures B. Kleinsorge University of Cambridge SINTEF Materials and Chemistry 2005 Tyndall National Institute Lee Maltings University College Cork Printedin Belgium PRINTED ON WHITE CHLORINE-FREE PAPER Nanomedicine Nanotechnology for Health European Technology Platform Strategic Research Agenda for Nanomedicine November .